Glycocalyx disruption mediates HP-PRRSV-induced microvascular endothelial dysfunction and underlies astragalus

Nuohan Xia1, Jian Sun2, Ge Hu1

  • 1Beijing Key Laboratory of Traditional Chinese Veterinary Medicine, Animal Science and Technology College, Beijing University of Agriculture, Beijing, China.

Abstract

Insights

Astragalus polysaccharide (APS) protects pulmonary microvascular endothelial cells (MVECs) from highly pathogenic porcine reproductive and respiratory syndrome virus (HP-PRRSV) by maintaining glycocalyx integrity. Glycocalyx disruption worsens HP-PRRSV-induced lung injury, while APS treatment restores endothelial function.

Area of Science:

  • Veterinary Virology
  • Cell Biology
  • Immunology

Background:

  • Pulmonary microvascular endothelial cells (MVECs) are key targets and inflammatory hubs during highly pathogenic porcine reproductive and respiratory syndrome virus (HP-PRRSV) infection.
  • Glycocalyx disruption in MVECs initiates functional disorders, and astragalus polysaccharide (APS) is known to improve its integrity.

Purpose of the Study:

  • To investigate the role of glycocalyx disruption in HP-PRRSV-induced pulmonary microvascular endothelial dysfunction.
  • To determine the contribution of the glycocalyx to the therapeutic efficacy of APS against HP-PRRSV.

Main Methods:

  • HP-PRRSV infection of porcine pulmonary MVECs, treated with APS with or without prior glycocalyx degradation (heparinase III).
  • Analysis of glycocalyx components, viral protein, adhesion molecules, barrier function (TEER, HRP-SA permeability), and neutrophil function.
  • Detection methods included western blotting, flow cytometry, and Transwell assays.

Main Results:

  • HP-PRRSV infection reduced key glycocalyx components and induced endothelial dysfunction (decreased TEER, increased permeability, elevated adhesion molecules), and impaired neutrophil function.
  • APS treatment alleviated HP-PRRSV-induced damage, suppressed viral replication, and restored endothelial and neutrophil functions.
  • Enzymatic removal of the glycocalyx exacerbated injury and diminished APS efficacy.

Conclusions:

  • Glycocalyx disruption is a critical factor in HP-PRRSV-induced pulmonary microvascular endothelial dysfunction.
  • APS exerts therapeutic effects by preserving glycocalyx integrity and function, offering a novel therapeutic mechanism.

Related Concept Videos

Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...